Administration of oxytocin as an ultra-fine powder to the airways of postpartum sheep led to rapid systemic absorption, resulting in uterine electromyographic activity comparable to that induced by intramuscular injection, the current first line therapy for the prevention of PPH in resource-poor settings. Here, OXT is linked to pulmonary arterial hypertension.